PSTI - プルリステム・セラピュ―ティクス (Pluristem Therapeutics Inc.)

PSTIのニュース

   Pluristem Up 6% In Pre-Market On German Clearance For Covid-19 Study  2020/08/10 12:44:13 Smarter Analyst
Shares in Pluristem Therapeutics (PSTI) rose 6% in Monday’s pre-market trading after Germany’s health regulatory agency, the Paul Ehrlich Institute (PEI), approved Pluristem’s … The post Pluristem Up 6% In Pre-Market On German Clearance For Covid-19 Study appeared first on Smarter Analyst .
   Agenus : B Riley FBR Virtual Infectious Disease Summit Transcript | MarketScreener  2020/08/07 12:22:49 MarketScreener
Below is an unedited transcript from the B. Riley FBR Infectious Disease Summit Part III with Agenus, Inc. Excision BioTherapeutics, and Pluristem Therapeutics hosted by Mayank Mamtani… | August 7, 2020
   Is Pluristem Therapeutics (PSTI) Outperforming Other Medical Stocks This Year?  2020/05/15 15:30:15 Zacks Investment Research
Is (PSTI) Outperforming Other Medical Stocks This Year?
   Pluristem Provides 28-Day Follow Up for Ventilator-Dependent COVID-19 Patients under Compassionate Use Program in Israel and U.S.  2020/05/14 12:00:00 GlobeNewswire
Update is provided in advance of the company’s recruitment of first patient for its phase II Covid-19 study
   The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda  2020/05/08 11:59:45 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 7) • Acceleron Pharma Inc (NASDAQ: XLRN ) • Bio-Rad Laboratories, Inc. (NYSE: BIO ) • BIO-TECHNE Corp (NASDAQ: TECH ) • Catalent Inc (NYSE: CTLT ) • Cytosorbents Corp (NASDAQ: CTSO ) • DexCom, Inc. (NASDAQ: DXCM ) • GENMAB A/S/S ADR (NASDAQ: GMAB ) • Immunomedics, Inc. (NASDAQ: IMMU ) • Immunovant Inc (NASDAQ: IMVT ) • Kala Pharmaceuticals Inc (NASDAQ: KALA ) • Masimo Corporation (NASDAQ: MASI ) • Meridian Bioscience, Inc. (NASDAQ: VIVO ) • Minerva Neurosciences Inc (NASDAQ: NERV ) • Natera Inc (NASDAQ: NTRA ) • ORIC Pharmaceuticals Inc (NASDAQ: ORIC ) • Phathom Pharmaceuticals Inc (NASDAQ: PHAT ) • Quidel Corporation (NASDAQ: QDEL ) • Repligen Corporation (NASDAQ: RGEN ) • Revolution Medicines Inc (NASDAQ: RVMD ) • Scpharmaceuticals Inc (NASDAQ: SCPH ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 7) • Apyx Medical Corp (NASDAQ: APYX ) • Biofrontera AG (NASDAQ: BFRA ) • Sonnet Biotherapeutics Holdings Inc (NASDAQ: SONN ) Stocks In Focus Pluristem Gets FDA Nod To Initiate Phase 2 Study Of PLX Cells In COVID-19 Pluristem Therapeutics Inc. (NASDAQ: PSTI ) said the FDA cleared its IND application …
   Pluristem Up 6% In Pre-Market On German Clearance For Covid-19 Study  2020/08/10 12:44:13 Smarter Analyst
Shares in Pluristem Therapeutics (PSTI) rose 6% in Monday’s pre-market trading after Germany’s health regulatory agency, the Paul Ehrlich Institute (PEI), approved Pluristem’s … The post Pluristem Up 6% In Pre-Market On German Clearance For Covid-19 Study appeared first on Smarter Analyst .
   Agenus : B Riley FBR Virtual Infectious Disease Summit Transcript | MarketScreener  2020/08/07 12:22:49 MarketScreener
Below is an unedited transcript from the B. Riley FBR Infectious Disease Summit Part III with Agenus, Inc. Excision BioTherapeutics, and Pluristem Therapeutics hosted by Mayank Mamtani… | August 7, 2020
   Is Pluristem Therapeutics (PSTI) Outperforming Other Medical Stocks This Year?  2020/05/15 15:30:15 Zacks Investment Research
Is (PSTI) Outperforming Other Medical Stocks This Year?
   Pluristem Provides 28-Day Follow Up for Ventilator-Dependent COVID-19 Patients under Compassionate Use Program in Israel and U.S.  2020/05/14 12:00:00 GlobeNewswire
Update is provided in advance of the company’s recruitment of first patient for its phase II Covid-19 study
   The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda  2020/05/08 11:59:45 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 7) • Acceleron Pharma Inc (NASDAQ: XLRN ) • Bio-Rad Laboratories, Inc. (NYSE: BIO ) • BIO-TECHNE Corp (NASDAQ: TECH ) • Catalent Inc (NYSE: CTLT ) • Cytosorbents Corp (NASDAQ: CTSO ) • DexCom, Inc. (NASDAQ: DXCM ) • GENMAB A/S/S ADR (NASDAQ: GMAB ) • Immunomedics, Inc. (NASDAQ: IMMU ) • Immunovant Inc (NASDAQ: IMVT ) • Kala Pharmaceuticals Inc (NASDAQ: KALA ) • Masimo Corporation (NASDAQ: MASI ) • Meridian Bioscience, Inc. (NASDAQ: VIVO ) • Minerva Neurosciences Inc (NASDAQ: NERV ) • Natera Inc (NASDAQ: NTRA ) • ORIC Pharmaceuticals Inc (NASDAQ: ORIC ) • Phathom Pharmaceuticals Inc (NASDAQ: PHAT ) • Quidel Corporation (NASDAQ: QDEL ) • Repligen Corporation (NASDAQ: RGEN ) • Revolution Medicines Inc (NASDAQ: RVMD ) • Scpharmaceuticals Inc (NASDAQ: SCPH ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 7) • Apyx Medical Corp (NASDAQ: APYX ) • Biofrontera AG (NASDAQ: BFRA ) • Sonnet Biotherapeutics Holdings Inc (NASDAQ: SONN ) Stocks In Focus Pluristem Gets FDA Nod To Initiate Phase 2 Study Of PLX Cells In COVID-19 Pluristem Therapeutics Inc. (NASDAQ: PSTI ) said the FDA cleared its IND application …
   The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda  2020/05/08 11:59:45 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 7) • Acceleron Pharma Inc (NASDAQ: XLRN ) • Bio-Rad Laboratories, Inc. (NYSE: BIO ) • BIO-TECHNE Corp (NASDAQ: TECH ) • Catalent Inc (NYSE: CTLT ) • Cytosorbents Corp (NASDAQ: CTSO ) • DexCom, Inc. (NASDAQ: DXCM ) • GENMAB A/S/S ADR (NASDAQ: GMAB ) • Immunomedics, Inc. (NASDAQ: IMMU ) • Immunovant Inc (NASDAQ: IMVT ) • Kala Pharmaceuticals Inc (NASDAQ: KALA ) • Masimo Corporation (NASDAQ: MASI ) • Meridian Bioscience, Inc. (NASDAQ: VIVO ) • Minerva Neurosciences Inc (NASDAQ: NERV ) • Natera Inc (NASDAQ: NTRA ) • ORIC Pharmaceuticals Inc (NASDAQ: ORIC ) • Phathom Pharmaceuticals Inc (NASDAQ: PHAT ) • Quidel Corporation (NASDAQ: QDEL ) • Repligen Corporation (NASDAQ: RGEN ) • Revolution Medicines Inc (NASDAQ: RVMD ) • Scpharmaceuticals Inc (NASDAQ: SCPH ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 7) • Apyx Medical Corp (NASDAQ: APYX ) • Biofrontera AG (NASDAQ: BFRA ) • Sonnet Biotherapeutics Holdings Inc (NASDAQ: SONN ) Stocks In Focus Pluristem Gets FDA Nod To Initiate Phase 2 Study Of PLX Cells In COVID-19 Pluristem Therapeutics Inc. (NASDAQ: PSTI ) said the FDA cleared its IND application …
   Pluristem Announces Pricing of Its Registered Direct Offering for Aggregate Proceeds of $15 Million  2020/05/05 13:56:00 GlobeNewswire
HAIFA, Israel, May 05, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing…
   Pluristem Therapeutics Inc. (PSTI) Shares March Higher, Can It Continue?  2020/05/01 10:39:00 Zacks Investment Research
As of late, it has definitely been a great time to be an investor in Pluristem Therapeutics Inc. (PSTI).
   Here's Why Momentum Investors Will Love Pluristem (PSTI)  2020/04/30 16:00:19 Zacks Investment Research
Does Pluristem (PSTI) have what it takes to be a top stock pick for momentum investors? Let's find out.
   Has Pluristem Therapeutics (PSTI) Outpaced Other Medical Stocks This Year?  2020/04/29 15:30:12 Zacks Investment Research
Is (PSTI) Outperforming Other Medical Stocks This Year?

calendar